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Summary
A transgenic mouse model of T cell lymphoma was used to investigate the transforming events mediated by an oncogenic
tyrosine kinase in pretumorigenic CD4CD8 (DN) thymocytes. Parental CD45/ and p56lck-F505Y mice do not develop tumors,
whereas their CD45/p56lck-F505Y progeny develop T lymphomas. Increased but nononcogenic p56lck kinase activity in
p56lck-F505Y mice DN thymocytes causes cell-cycle progression, survival, and Bcl-XL upregulation. Additional unique oncogenic
signals occur in pretumorigenic CD45/p56lck-F505Y thymocytes in which p56lck kinase activity is 2- to 3-fold higher relative
to p56lck-F505Y: inhibition of DNA repair, inhibition of DNA-damage-induced Bcl-XL deamidation, Bax conformational change
and mitochondrial translocation, cytochrome c release, and the apoptotic caspase execution cascade. Inhibition of Bcl-
XL deamidation may be a critical switch in oncogenic kinase-induced T cell transformation.
Introduction hallmarks of cellular transformation (Hanahan and Weinberg,
2000). The actions of OTKs in regulating these processes have
been investigated mainly using transformed cells, whereas lessThere are more than 90 protein tyrosine kinases in the human
genome, of which 30 have been implicated in cancer. The onco- information is available concerning the role of OTKs in early
oncogenic events in primary cells. The murine thymus providesgenic tyrosine kinases (OTKs) promote growth factor-indepen-
dent cell proliferation, protect cells from apoptosis, and render a useful experimental system for the investigation of such
events. The CD4CD8 (double negative, DN) thymic popula-cells resistant to genotoxic therapies (Skorski, 2002). The OTKs
employ a wide range of strategies for subverting the normal tion, comprising 1%–3% of the adult thymus, can be subdivided
into four discrete developmental stages: the CD25CD44linkage between DNA damage and cell death. Some OTKs, such
as BCR-ABL, inhibit DNA repair (Deutsch et al., 2001), whereas (DN1), CD25CD44 (DN2), CD25CD44 (DN3), and CD25
CD44 (DN4) subsets (Rodewald and Fehling, 1998). Successfulothers enhance DNA repair mechanisms in transformed cells,
contributing to their genotoxic resistance (Slupianek et al., TCR rearrangements lead to expression of the pre-TCR on
DN3 thymocytes and the subsequent p56lck tyrosine kinase-2002). In addition, OTKs transmit survival signals that counteract
DNA-damage-induced apoptosis (Jain et al., 1996; Skorski, dependent mediation of survival and proliferative signals in a
process known as  selection.2002). For example, OTKs have been reported to upregulate
the antiapoptotic proteins Bcl-2 and Bcl-XL (Kumar et al., 1996; We have recently generated a mouse cancer model in which
aggressive T lineage thymic tumors develop in 100% of CD45/Amarante-Mendes et al., 1998), and to inhibit the proapoptotic
proteins Bcl-2-associated X protein (BAX) (Wang et al., 1999) animals expressing mutant p56lck-F505 in which the inhibitory regu-
latory Tyr-505 at the C terminus has been mutated to a Pheand Bcl-2 antagonist of cell death (BAD) (Salomoni et al., 2000).
Recently Bcl-XL deamidation in response to DNA damage has (Baker et al., 2000). CD45 is a transmembrane tyrosine phospha-
tase that is expressed abundantly on hematopoietic cells (Alex-also been described (Deverman et al., 2002), although no link
to an OTK has yet been made and the possible role of Bcl-XL ander, 1997), and CD45/ mice are characterized by defects
in thymic development but no tumorigenesis (Byth et al., 1996).deamidation in oncogenesis remains unknown.
The prevention of DNA-damage-induced apoptosis by the In the parental low copy number lckF505 (PLGF-A) mice bred
with CD45/ mice, the mutant lck transgene causes prematureinappropriate upregulation of survival pathways is one of the
S I G N I F I C A N C E
We have shown that an oncogenic tyrosine kinase inhibits DNA repair in pretumorigenic primary murine thymocytes, resulting in
genomic instability and chromosomal aberrations. Elimination of the DNA-damaged cells is blocked by a powerful prosurvival
pathway that inhibits the mitochondrial-regulated cascade of events that lead to apoptosis. This pathway prevents the Bcl-XL
deamidation that normally occurs following DNA damage and preserves the ability of Bcl-XL to sequester a proapoptotic BH3-only-
containing protein such as Bim. The oncogenic kinase therefore appears to transform T cells by a “double whammy” whereby DNA
damage is promoted but Bcl-XL prosurvival functionality is simultaneously maintained, thereby disrupting the cancer protection
pathway that normally disposes of cells with damaged DNA.
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allelic exclusion, but no tumors; much higher expression of tive lck transgene promotes the DN to DP transition (Pingel et
al., 1999). Figure 1A (upper panel) shows that pTyr-505 wasthe active lckF505 transgene can generate thymic tumors in the
CD45/ thymus (Abraham et al., 1991). On a CD45/ back- hyperphosphorylated in CD45/Rag-1/ compared to Rag-
1/ DN thymocytes, consistent with our previous results usingground, the positive regulatory Tyr-394 site in p56lck becomes
hyperphosphorylated in the low copy number lckF505 (PLGF-A) whole thymocytes (Stone et al., 1997). As expected, pTyr-505
phosphorylation was not prominent in cells expressing the mu-murine thymocytes, presumably because CD45 is not available
to dephosphorylate this residue, thereby switching the p56lck tant lckF505 transgene. There was a marked 4-fold increase in
pTyr-394 phosphorylation in Rag-1/CD45/LckF505 com-kinase to a hyperactive oncogenic state (Baker et al., 2000).
The CD45/LckF505 tumor cells are phenotypically characteristic pared to Rag-1/LckF505 thymocytes. In vitro kinase assays
revealed that the p56lck kinase activity was more than 5-foldof the DN3/DN4 stage of thymic differentiation. Tumor incidence
is the same in CD45/LckF505 mice backcrossed to the Rag- higher in Rag-1/CD45/LckF505 compared to Rag-1/ DN
thymocytes, and more than 2-fold higher when compared with1/ background (Baker et al., 2000).
In the present work we have analyzed the signaling pathways Rag-1/CD45/ or Rag-1/LckF505 mice (Figure 1B). Interest-
ingly, a prominent 34–36 kDa phosphorylated protein (as yetin pretumorigenic DN CD45/LckF505 thymocytes that lead to
transformation in relation to p56lck kinase activity and function. unidentified) was found in association with the high activity
p56lck. Overall, these results are consistent with the model thatWhereas the nononcogenic “intermediate level” mutant p56lck-F505
activity (Alexander, 2000) induces a powerful survival signal in CD45 can dephosphorylate both pTyr-394 and pTyr-505 p56lck
regulatory sites in DN thymocytes. Furthermore, p56lck kinaseRag/CD45/ thymocytes, involving Bcl-XL upregulation and
causing rescue of the DN3 and DN4 subsets from apoptosis, activities in DN thymocytes may be defined as basal (Rag-1/),
intermediate (Rag-1/CD45/ or Rag-1/LckF505), or hyperac-the oncogenic hyperactive mutant p56lck-F505 activity that charac-
terizes CD45/LckF505 thymocytes triggers two additional criti- tive (Rag-1/CD45/LckF505) (Alexander, 2000). Further studies
were directed toward answering the key question: what are thecal signals: inhibition of DNA damage repair, leading to marked
genomic instability, and stimulation of a distinct survival path- signaling switches triggered by oncogenic hyperactive p56lck
that are distinct from those induced by nononcogenic intermedi-way that prevents DNA-damage-induced apoptosis.
ate activity p56lck?
Results
Intermediate activity and hyperactive p56lck are equally
proficient in promoting the survival and cell cyclep56lck is hyperactive in DN CD45/LckF505 thymocytes
Four different mouse lines were used to carry out this study: progression of DN thymocytes
We considered that hyperactive p56lck might trigger oncogenicwild-type C57BL/6, LckF505 (PLGF-A), CD45/, and the
CD45/LckF505 progeny of LckF505  CD45/ crosses. Only the events by causing abnormally high survival of DN3 thymocytes
that fail  selection and/or by perturbing the cell cycle. ThisCD45/LckF505 progeny developed thymic tumors. All experi-
ments described were carried out on pretumorigenic thymo- question is most readily addressed using Rag-1/ thymocytes
in which the complete failure of  selection leads to a high levelcytes from 5- to 8-week-old mice. In addition, we utilized for
technical reasons the same lines backcrossed to a Rag-1/ of thymic apoptosis (Falk et al., 2001). Figure 2 shows that in
the Rag-1/ DN3 subset, 90% or more of cells are apoptotic.background. Flow cytometric analyses of the mice used for this
study can be found in the Supplemental Data (Supplemental However, even the 2-fold higher p56lck activity found in Rag-
1/CD45/ thymocytes is sufficient to rescue about 70% ofFigure S1 at http://www.cancercell.org/cgi/content/full/5/1/37/
DC1). Figure 1A (middle panel) shows that the expression of the cells, and essentially, complete rescue was induced by the
mutant kinase transgene in both Rag-1/LckF505 and Rag-p56lck in DN thymocyte lysates from the lines expressing the
mutant LckF505 transgene was 2.3  0.2 (n  4) fold higher 1/CD45/LckF505 thymocytes. The greater prosurvival po-
tency of “intermediate activity” mutant p56lck-F505, when com-than wild-type or CD45/ DN thymocytes. We have previously
shown that the p56lck kinase activity in CD45/LckF505 thymo- pared to wild-type p56lck on a CD45/ background, is most
likely explained by the greater accessibility of the noncatalyticcytes is increased about 2-fold in relation to wild-type thymo-
cytes, correlating with increased phosphorylation at the positive domains in the mutant Y505F form of the kinase (Stone et al.,
1997; Lin et al., 2000).regulatory site Tyr-394 (Baker et al., 2000). A more detailed
analysis of these parameters was necessary for two reasons: We next investigated the cell cycle by assessing 7-AAD
staining in DN subsets. As expected, nearly all Rag-1/ andfirst, our earlier biochemical studies were carried out using whole
thymocytes, whereas transformation occurs at the DN differenti- Rag-1/CD45/ DN3 cells were in growth arrest due to their
lack of pre-TCR mediated mitogenic signals, whereas LckF505,ation stage (Baker et al., 2000) and the regulation of p56lck could
differ between the dominant DP and minor DN subsets; second, as previously described (Pingel et al., 1999), promoted cell-
cycle progression (Figure 3A). Significantly, however, the per-the commercial antibody that we used in our previous study to
measure p56lck Tyr-394 phosphorylation (Baker et al., 2000) was, centages of DN3 and DN4 Rag-1/CD45/LckF505 thymocytes
in cycle were no greater or less despite their hyperactive p56lck.in the interim, withdrawn. We have therefore obtained a new
and well-characterized pTyr-394 antibody (Holdorf et al., 2002) Furthermore, detailed analysis of the percentages of DN3 and
DN4 cells in the S, G2, and M phases of the cell cycle revealedfor use in the present work.
To facilitate the analysis of p56lck in DN subsets, we utilized no significant differences between the Rag-1/LckF505 and Rag-
1/CD45/LckF505 thymus (data not shown). We consideredmice on the Rag-1/ background, since virtually all thymocytes
in Rag-1/ and Rag-1/CD45/mice are CD4CD8. In addi- that in vivo BrdU incorporation might provide a more dynamic
insight into the turnover of thymic subsets. Figure 3B showstion, highly purified DN subsets were prepared from Rag-
1/LckF505 and Rag-1/ CD45/LckF505 mice in which the ac- that whereas DNA synthesis was markedly suppressed in Rag-
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Figure 1. p56lck pTyr-394 phosphorylation and kinase activity are upregulated in Rag/CD45/LckF505 DN thymocytes
A: Immunoprecipitated p56lck from DN thymocytes was blotted for p-Tyr394, followed by stripping and reprobing for p-Tyr505, and then for p56lck protein
to demonstrate comparable loading (upper panel). The histogram data represent means SD from five independent experiments and are expressed as
relative phosphorimager values normalized for p56lck loading. Whole cell lysates were immunoblotted for p56lck and phosphorimager values (see text)
normalized using actin as a loading control (middle panel).
B: In vitro kinase assays of p56lck immunoprecipitated from DN thymocytes immunoblotted for p56lck to show comparable loading. The histogram shows
mean p56lck relative autophosphorylation values from three independent experiments normalized for p56lck loading.
1/ and Rag-1/CD45/ DN3 cells and, as expected, pro- parison with CD45/ and LckF505 thymocytes (viz. about 70%
of DNA still contained DSBs compared to 15%–20% in themoted by LckF505, no greater increase in DNA synthesis was
control cells). The increase in DNA molecular weight to 5.7observed in DN3 and DN4 pretumorigenic Rag-1/CD45/
Mb from 1.7–3.0 Mb in control cells at 6 hr (lanes 11–13) confirmsLckF505 as compared to Rag-1/LckF505 thymocytes.
that repair was occurring, and this partial repair was also muchOverall, these results show that DN3/DN4 thymocyte sur-
reduced in pretumorigenic thymocytes (lane 14). The rapidityvival and cell cycle progression are exquisitely sensitive to the
of fragmentation after irradiation and the pattern of repair con-p56lck activity level, but the data do not discriminate between the
firm that these results represent DNA damage and repair, andoncogenic and nononcogenic consequences of p56lck signaling.
not apoptosis (Cohen et al., 1994). Overall, the data show that
one or more DNA repair mechanisms is strongly inhibited only
Hyperactive p56lck-F505 inhibits DNA repair and promotes
in the cells expressing oncogenic hyperactive p56lck-F505.
genomic instability It is thought that of all forms of DNA damage, DSBs are
We used pulsed field gel electrophoresis (PFGE) to assess the particularly potent in generating genomic instability (Khanna and
efficiency of DNA repair mechanisms (De Silva et al., 2000). Jackson, 2001), resulting in chromosomal translocations with
Purified DN thymocytes were exposed to ionizing irradiation, oncogenic potential (Richardson and Jasin, 2000). We therefore
then fixed immediately or left for 6 hr or 24 hr for DNA repair carried out two separate types of assay to assess genomic
to occur before assessing the level of DNA damage. Figure 4Aa instability in the primary pretumorigenic CD45/LckF505 DN thy-
shows that the rapid increase in DSBs following irradiation, mocytes. The first depends on the finding that DSBs induce
as revealed by the decrease in average fragment length, was histone H2AX phosphorylation on Ser-139 (Rogakou et al.,
comparable in the four mouse lines under investigation. Interest- 1998). Recently, H2AX has been shown to be an important
ingly, however, whereas DSB repair was essentially complete suppressor of oncogenic translocations and tumors (Bassing
after 24 hr in the thymocytes with basal and intermediate p56lck et al., 2003). Figure 4Ab shows that a phosphospecific antibody
activities, in DN CD45/LckF505 thymocytes, repair was mark- against -H2AX, the phosphorylated form of the protein, revealed
edly inhibited. The repair efficiency in the thymocytes expressing a strong signal by immunoblotting in purified CD45/LckF505
DN thymocytes, but not in control cells. The flow cytometriconcogenic LckF505 was reduced by about 4-fold at 24 hr in com-
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Figure 2. The survival of DN3 thymocytes is pro-
moted to a comparable extent by nononco-
genic or oncogenic p56lck-F505
TUNEL assays were used to assess apoptosis in
gated DN3 cells represented by the gray line;
controls were carried out by adding all reagents
except for Tdt (dark area). The histogram is
based on four independent experiments and
shows mean TUNEL positive cells SD.
data illustrated in Figure 4Ac also show that the staining for morigenic DN thymocytes, consistent with an increased load
of DSBs. Since each DSB is thought to cause the phosphoryla--H2AX is about 5-fold higher in Rag/CD45/LckF505 DN3/4
thymocytes as compared to controls. Taken together, these tion of multiple H2AX molecules, this most probably explains
why this more sensitive assay reveals increased DSBs underresults demonstrate a higher level of -H2AX in primary pretu-
Figure 3. Nononcogenic or oncogenic LckF505 drives Rag/ and Rag/CD45/ DN3 and DN4 thymocytes into cell cycle to a comparable extent
A: Cell cycle analysis of DN3 and DN4 thymocytes based on 7-AAD staining. Percentages of the cells in the S/G2/M phases in the DN3 and DN4 subsets
are shown in each frame. The histogram is based on four independent experiments and shows means SD.
B: BrdU in vivo labeling. BrdU staining was measured in DN3 and DN4 subsets 2 hr postinjection. The histogram is based on five independent experiments
and shows means SD. Note that DN4 subsets are not shown for Rag/ and CD45/Rag/ subsets because development is blocked at the DN3 stage.
This also explains why the cell counts analyzed on the y axes are high for Rag/ and CD45/Rag/ DN3 subsets, but low when LckF505 is present, because
it causes progression to the DP maturation stage, so “emptying” the DN3 compartment (Supplemental Figure S1 at http://www.cancercell.org/cgi/content/
full/5/1/37/DC1).
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Figure 4. Oncogenic LckF505 inhibits DNA repair and promotes chromosomal instability
A: Analysis of DNA damage and repair in purified DN thymocytes. a: Pulse field gel electrophoresis analysis of DNA from  irradiated purified DN thymocytes.
Thymocytes from C57BL/6 (lanes 3, 7, 11, and 15), CD45/ (lanes 4, 8, 12, and 16), LckF505 (lanes 5, 9, 13, and 17) and CD45/LckF505 (lanes 6, 10, 14, and
18) mice were treated as indicated. The S. pombe (lane 1) and H. wingei (lane 2) chromosomes were used as DNA size markers (note that the markers
were clearer in the original gel than illustrated here). The results, based on 5 separate experiments, have been quantified by scanning the gel with a
phosphorimager and estimating the relative DSBs as the DNA remaining in the gel as a % of total DNA in each lane. b: DN thymocytes purified from
C57BL/6, CD45/, LckF505, and CD45/LckF505 mice were immunoblotted for H2AX. The membrane was stripped and reprobed for H2A. c: Expression of
H2AX analyzed by flow cytometry. Permeabilized thymocytes staining positive for FITC-conjugated CD3, CD4, CD8, and CD44 mAbs were gated out and
a biotinylated H2AX mAb was used to stain the DN3/DN4 thymic subsets.
B: Chromosomal aberrations (arrowed) in purified DN thymocytes revealed by rainbow FISH probes. a: P1 onto Mouse 5 (Rag/CD45/LckF505) showing a
t2;9 translocation. The derived chromosomes (colored mauve) are indicated as “der 2” and “der 9”: “der 2” is the derived chromosome that carries the
centromeric portion of chromosome 2. Note that chromosome 9 is invisible in this pool (see d for chromosome 9). b: DAPI-banded metaphase shown in
a. c: P2 onto Mouse 6 (Rag/CD45/LckF505) showing the trisomy 10. d: P2 onto Mouse 5 showing the t2;9 translocation. Note that only the green chromosome
9 portion of the translocation is present in this pool. The derived chromosomes are indicated as “der 2” and “der 9.” e: DAPI-banded metaphase shown
in d. f: P2 onto Mouse 9 (CD45/LckF505) showing a partial trisomy 12. g: P3 onto Mouse 6 (male) showing a trisomy 15. h: DAPI-banded metaphase shown
in g. i: P3 onto Mouse 5 (female) showing a trisomy 15.
C: Characterization of the karyotypes of MATT-1 and MATT-4 cell lines. a: Hybridization of mouse chromosome 4 paint (green) onto MATT-1 chromosomes
(red). b: Hybridization of mouse chromosome 14 paint (green) onto MATT-1 chromosomes (red). c: Simultaneous hybridization of mouse chromosome paints
6 (red) and 17 (green) onto MATT-1 chromosomes (blue). d: A bivariate flow karyotype of the MATT-1 cell line. e: Hybridization of paint from the der
(17)t(6;17) onto the C3H metaphase (red). f: Hybridization of mouse chromosome 15 paint (green) onto MATT-4 metaphase (red).
basal conditions, whereas PFGE does not (cf. Figure 4Aa lanes IL-4 to obtain metaphase spreads (Zlotnik et al., 1987). Flow
cytometric analysis confirmed that DN thymic subsets did not3–6).
In the second type of assay to assess genomic instability detectably change their surface marker phenotypes with refer-
ence to CD3, CD4, CD8, CD25, and CD44 under the culturewe carried out karyotype analysis by chromosome painting
(Ferguson-Smith, 1997) on purified DN thymocytes cultured in conditions used (data not shown). No chromosomal abnormali-
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ties were detected in 43 metaphase spreads from either thereby effecting escape from apoptotic surveillance (Bullock
and Fersht, 2001), we examined the ability of DNA damage toCD45/ or LckF505 control DN thymocytes (data not shown).
However, as Figure 4B illustrates, multiple chromosomal abnor- regulate p53 and its downstream effectors. Figure 5B shows that
DNA-damage-induced p53 protein and pSer-15 phoshorylationmalities were detected in pretumorigenic DN thymocytes from
three out of five CD45/LckF505 mice analyzed. Thus, Mouse 5 (Siliciano et al., 1997) levels were, if anything, higher in the
pretumorigenic LckF505CD45/ thymocytes than in the parentaldisplayed a t2;9 translocation (Figures 4Ba and 4Bd) and a
trisomy 15 (i), Mouse 6 a trisomy 10 (c) and a trisomy 15 (g), or wild-type controls. Furthermore, the downstream p53 ef-
fectors Mdm2, Bax, and p21WAF1 were likewise induced at some-and Mouse 9 a partial trisomy 12 (f). These results confirm
marked genomic instability uniquely in pretumorigenic DN what higher levels in the thymocytes expressing hyperactive
p56lck-F505 (Figure 5C). Interestingly, purified pretumorigenic DNCD45/LckF505 thymocytes. To establish whether chromosomal
abnormalities in tumor cells might be similar to those in the Rag/LckF505CD45/ thymocytes displayed increased p53 ac-
tivation even without prior DNA-damaging treatments, whereaspretumorigenic thymocytes, we established cell lines from the
tumors of individual CD45/LckF505 mice (MATT-1 and MATT-4) p53 was hyperactivated in LckF505CD45/ tumor cells (Figure
5D). Overall, these results demonstrate that the linkage betweenand carried out chromosomal analysis on early passage cells.
Hybridizations revealed multiple chromosomal abnormalities in- DNA damage and p53 regulation is intact in LckF505CD45/
thymocytes.volving trisomies of chromosomes 4, 6, and 14, an apparently
unbalanced 6:17 translocation in MATT-1 cells (Figures 4Ca–
4Ce), and a trisomy 15 in MATT-4 cells (Figure 4Cf). To deter- Oncogenic p56lck-F505 selectively inhibits Bcl-XL
deamidation, Bax translocation, and the caspase cascademine the origin of the 6:17 translocation in MATT-1 cells, the
derivative chromosome was sorted by flow cytometry (Figure Since p53 was clearly functional, we investigated the down-
stream caspase execution apparatus of the apoptotic pathway4Cd) and made into a paint, which was hybridized onto normal
metaphases from a C3H mouse (Figure 4Ce). Chromosome (Hengartner, 2000) and then worked back upstream to identify
the locus of action of oncogenic p56lck-F505. In mammals, cyto-painting revealed that the der(17)t(6:17) is composed of two
chromosomal segments: one segment from 6qF1-G3 and the chrome c initiates caspase activation following its release from
mitochondria and subsequent oligomerization with multimericother from 17qA1-E1, and that 17qE2-E5 has been deleted
during translocation (Figure 4Ce). Therefore, tumors from Apaf-1 to form the active apoptosome complex (Zou et al.,
1999; Wang, 2001a). This in turn activates procaspase-9, whichCD45/LckF505 mice also display evidence of chromosomal
damage, including nonreciprocal translocations, which are com- activates executioner caspases such as caspase-3 (Rodriguez
and Lazebnik, 1999), which in turn can cleave the 113 kDa formmon in human cancer but rare in mice.
Overall, these findings demonstrate a striking correlation of poly(ADP-ribose)polymerase (PARP) to yield an inactive 89
kDa fragment (Simbulan-Rosenthal et al., 1999). Figure 6Abetween inhibition of DNA repair and genomic instability in pri-
mary pretumorigenic DN thymocytes expressing oncogenic shows that whereas DNA damage induced effective PARP
cleavage in thymocytes expressing basal or intermediate p56lckp56lck-F505, although this did not result in consistent patterns
of chromosomal abnormality in either pretumorigenic or tumor activities, cleavage was almost completely inhibited in
LckF505CD45/ thymocytes. Inhibition of caspase-3 activationCD45/LckF505 cells.
following DNA damage was confirmed by the demonstration
that the conversion of 32 kDa procaspase-3 to active 17 kDaA powerful survival pathway prevents DNA-damage-
induced apoptosis in thymocytes expressing caspase-3 was blocked only in thymocytes expressing hyperac-
tive p56lck-F505 (Figure 6B).hyperactive p56lck-F505
We surmised that since DNA repair is inhibited and DNA damage Since our results suggested that caspase-9 activation was
inhibited, we next measured mitochondrial cytochrome c releaseincreases in primary DN thymocytes (Figure 4), the DNA damage
response that normally leads to apoptosis might be disrupted before and after cell exposure to etoposide. As Figure 6C illus-
trates, DNA damage triggered a marked release of cytochromein CD45/LckF505 thymocytes. To investigate this possibility,
we exposed thymocytes to ionizing irradiation or to etoposide c into the cytosol in C57BL/6, LckF505, and CD45/ thymocytes,
but release was barely detectable in LckF505 CD45/ thymocytes.and then investigated the sub-G1 peak of 7-AAD stained DN3
and DN4 cells to assess the extent of apoptosis (Figure 5A). It has previously been shown that translocation of the proapo-
ptotic molecule Bax to the mitochondria is critical in cytochromeThe marked increase in apoptosis that occurred in response to
DNA damage was comparable in C57BL/6, LckF505 and CD45/ c release (Gross et al., 1998). By stripping and reprobing the
membrane with Bax antibody, we showed that Bax translocationthymocytes, whereas in both the DN3 and DN4 LckF505CD45/
subsets, the sub-G1 peaks were close to untreated levels, to mitochondria was prevented only in LckF505CD45/ thymo-
cytes, correlating precisely with the block in cytochrome c re-indicating that only in the thymocytes expressing oncogenic
p56lck-F505 was there a powerful survival signal protecting the lease (Figure 6C). Mitochondrial and cytosolic fraction integrity
and equal loading were confirmed by further probing the West-cells from apoptosis. This is in sharp contrast to the comparable
efficiency of either intermediate or hyperactive p56lck in rescuing ern blot with antibodies for cytochrome oxidase subunit IV (Cox-
IV) and tubulin, respectively. A conformational change in BaxDN thymocytes from apoptosis following the failure of  selec-
tion (Figure 2). precedes its translocation to mitochondria, and the 6A7 mAb
recognizes an epitope in its N terminus that becomes exposedA hallmark of DNA damage in normal cells is the induction,
phosphorylation, and consequent activation of the p53 tran- during apoptotic signaling (Hsu and Youle, 1998; Nechushtan
et al., 1999). We therefore immunoprecipitated Bax with 6A7scription factor resulting in cell cycle arrest and apoptosis (Sherr
and McCormick, 2002; Vousden and Lu, 2002). Since the func- mAb from thymic lysates before and after etoposide treatment,
using Chaps detergent to preserve the integrity of the epitope,tional loss of p53 is a common characteristic of tumor cells,
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Figure 5. Oncogenic LckF505 inhibits DNA-damage-induced apoptosis but not p53 induction
A: Thymocytes were nonexposed (Ctrl) or exposed to 10 Gy  irradiation (IR), then cultured in appropriate media or in the presence of 50 	M etoposide
(Etop), before staining with 7-AAD, and subjected to FACS analysis 24 hr later. A representative experiment is shown and the histogram illustrates the means
from five independent experiments SD, including both the IR and Etop data.
B: Thymocytes were exposed to DNA-damaging conditions as in A followed by immunoblotting for p53 or pSer-15-p53. The membrane was stripped and
reprobed for actin to confirm comparable loading.
C: Immunoblotting for Mdm2, Bax, and p21WAF-1 on the same membrane, with actin for loading, using the same experimental conditions as in B.
D: DN thymocytes purified from Rag/LckF505 and Rag/CD45/LckF505 mice (5 of each), or thymocytes from Rag/, Rag/CD45/, and C57BL/6 mice,
or Rag/CD45/LckF505 tumor cells, were immunoblotted for p53, pser15-p53, and Mdm2 (107 cells per track).
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Figure 6. Oncogenic LckF505 inhibits DNA-dam-
age-induced Bax conformational change, Bax
translocation, cytochrome c release, and the
caspase activation cascade
Cells were treated exactly as in Figure 5 and
immunoblotted as shown.
A: Immunoblotting was performed using a mAb
that recognizes the full length and cleaved forms
of PARP.
B: A caspase-3 ab was used that detects both
the pro- (p32) and activated (p17) forms of cas-
pase-3.
C: Cytosolic and mitochondrial fractions were
immunoblotted for cytochrome c and Bax. The
membrane was stripped and reprobed for cyto-
chrome oxidase subunit IV (COX-IV) and

-tubulin as markers for mitochondria and cyto-
sol, respectively.
D: Cells were cultured with or without etoposide
for 24 hr, then lysed with buffer containing either 1% Triton X-100 (T100) or 1% Chaps (Chps). The change in Bax conformation was measured by immunoprecipi-
tating Bax with the 6A7 mAb followed by immunoblotting with a polyclonal Bax ab.
followed by immunoblotting for Bax. Parallel immunoprecipita- vival function of Bcl-XL (Deverman et al., 2002). Figure 7A (lower
panel) shows that in untreated thymocytes, Bcl-XL migrates astions were carried out using Triton X-100 lysates as a positive
control, as this detergent changes Bax conformation to expose a doublet, and that the faster migrating species effectively disap-
pears following DNA damage. This is consistent with the previ-the 6A7 epitope (Hsu and Youle, 1998). Figure 6D shows that
DNA damage caused a striking change in Bax conformation ous work based on an osteosarcoma cell line demonstrating
that this shift is caused by the deamidation of two asparaginein thymocytes expressing basal or intermediate activity p56lck,
whereas this conformational change was blocked in the pres- residues (Asn 52 and Asn 66) (Deverman et al., 2002; Aritomi
et al., 1997). Remarkably, this characteristic shift did not occurence of hyperactive p56lck. These results suggest that the sur-
vival pathway mediated by oncogenic p56lck-F505 lies upstream in LckF505CD45/ thymocytes following exposure to either eto-
poside or  irradiation (Figure 7A), suggesting that oncogenicof Bax conformational change.
Proapoptotic Bcl-2 members can be divided into the “multi- p56lck-F505 inhibits deamidation. Since the antiapoptotic function
of Bcl-XL mirrors its ability to sequester BH3-only proteinsdomain” family members, which possess homology in BH1-3
domains, such as Bax, and the “BH3 domain only” members, (Cheng et al., 2001), we investigated Bcl-XL binding to Bim
as an exemplar of this interaction. Figure 7B shows that afterwhich display sequence homology only within this critical death
domain (Huang and Strasser, 2000). It is thought that the BH1-3 etoposide treatment, the Bcl-XL level found in Bim immunopre-
cipitates was much higher in hyperactive p56lck-F505 thymocytesproteins may be the primary effectors of apoptosis, whereas
the BH3-only proteins regulate Bax or Bak functions. For exam- than in cells expressing basal or intermediate p56lck activity
levels. Likewise, the Bim signal was elevated uniquely in Bcl-ple, the BH3-only proteins Bid or Bim bind to Bax to promote the
release of mitochondrial proteins, and antiapoptotic molecules XL immunoprecipitates from LckF505CD45/ thymocytes (Figure
7B). Three splice forms of Bim have been described: BimS, BimL,such as Bcl-2 or Bcl-XL can act by binding and sequestering
Bid or Bim, thereby preventing their proapoptotic interactions and BimEL (O’Connor et al., 1998), and of these, at least two
(BimL and BimEL) were clearly identifiable in Bcl-XL immunopre-with Bax (Cheng et al., 2001; Kuwana et al., 2002). We first
showed (by FACS analysis) that Bcl-2 expression levels are cipitates. A further unidentified isoform was also noted migrating
between BimL and BimEL (Figure 7B) that could represent a novelcomparable between the DN1-DN4 thymic subsets in the four
mouse lines under investigation (data not shown). By contrast, splice form (Marani et al., 2002). Overall, these results show
that oncogenic p56lck-F505 induces signaling pathway(s) that in-immunoblotting revealed that Bcl-XL expression was increased
in both Rag-1/LckF505 and Rag-1/CD45/LckF505 purified hibit Bcl-XL deamidation and that preserve its binding to the
BH3-only protein Bim.DN thymocytes relative to controls, and tumor cell expression
was even higher (Figure 7A, upper panel). FACS analysis of The workers who first described DNA-damage-induced Bcl-
XL deamidation showed that Retinoblastoma (Rb) expressionspecific DN Rag/ thymic subsets stained for Bcl-XL showed
that whereas expression in DN3 cells was comparable in the caused inhibition of Bcl-XL deamidation using their cell line sys-
tem (Deverman et al., 2002). This is consistent with the demon-four lines under investigation, distinct Bcl-XL and Bcl-XLpopu-
lations of CD45/ DN4 cells were detectable (data not shown). stration that Rb is a potent inhibitor of apoptosis during the
DNA damage response (Wang et al., 2001b). We therefore ex-However, in both the LckF505 and CD45/LckF505 thymus, the
DN4 cells were nearly all Bcl-XL, consistent with the results amined the expression and phosphorylation status of Rb in
murine thymocytes. As expected, DNA damage triggered ashown in Figure 7A. Since the increase in Bcl-XL expression
was comparable in the “intermediate” and “hyperactive” p56lck characteristic shift in Rb migration due to its reduced phosphor-
ylation and consequent activation. However, this was compara-kinase activity cells, this observation alone does not explain why
only the Rag/CD45/LckF505 thymocytes develop tumors. ble in all four phenotypes, and we found no evidence that either
Rb expression or Rb dephosphorylation was different in theInterestingly, Bcl-XL deamidation in response to DNA dam-
age has been proposed as a critical switch to subvert the prosur- LckF505CD45/ compared to other thymocytes (Figure 7C).
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Figure 7. Oncogenic LckF505 inhibits Bcl-XL deami-
dation induced by DNA damage
A: Upper panel: DN thymocytes purified from
Rag/LckF505 and Rag/CD45/LckF505 mice (5
of each), or thymocytes from Rag/, Rag/
CD45/, and C57BL/6 mice, or Rag/CD45/
LckF505 tumor cells, were immunoblotted for Bcl-
Xl. The membrane was stripped and reprobed
for  actin to show comparable loading. Lower
panel: DNA damage was induced as in Figure
5 and whole cell lysates then immunoblotted for
Bcl-XL.
B: Cells were treated with 20 	M etoposide for
24 hr and immunoprecipitations were performed
using an antibody against Bim (left panel) or Bcl-
XL (right panel), respectively, followed by immu-
noblotting as indicated. Five separate experi-
ments each were performed for the Bim and
Bcl-XL immunoprecipitations, respectively, with
comparable results.
C: Immunoblotting of thymic lysates was carried
out with a mAb recognizing both the phosphory-
lated and dephosphorylated forms of Rb.
Therefore, regulation of Rb expression or activation in response to switch on an ensemble of signals that are unique to the
to DNA damage may not explain the inhibition of Bcl-XL deami- DN thymocytes destined to develop T cell lymphomas. This
dation observed in thymocytes. oncogenic ensemble includes the inhibition of DNA repair and
the resulting increase in DNA damage (Figure 4), the inhibition
Discussion of DNA-damage-induced Bcl-XL deamidation (Figure 7A), the
preservation of Bcl-XL sequestering functionality (Figure 7B),
The transgenic mouse lines investigated in this study provide and inhibition of Bax conformation change (Figure 6D), Bax
an experimental system in which the distinctive transforming mitochondrial translocation (Figure 6C), cytochrome c release
signals mediated by an oncogenic tyrosine kinase can be dis- (Figure 6C), and the apoptotic downstream caspase execution
criminated from the survival and proliferative signals that regu- cascade (Figure 6). Out of this ensemble, the prevention of Bcl-
late early thymic differentiation. A 2- to 3-fold increase in p56lck XL deamidation in the context of primary thymocytes undergoing
kinase activity (Figure 1) has the capacity, as Figure 8 illustrates, transformation and the concomitant preservation of its ability
to bind Bim are of particular interest. Our choice of Bim as an
exemplar to test the ability of Bcl-XL to sequester a BH3-only
protein was based on our technical ability to measure endoge-
nous Bcl-XL-Bim interactions in primary murine thymocytes,
thereby facilitating direct comparison with previous work per-
formed using a transfected cell line (Deverman et al., 2002).
Identification of the BH3-only protein(s) actually involved in the
DNA damage response in DN thymocytes will require further
analysis.
Until recently, protein deamidation has been considered as
a molecular timer, regulating protein turnover and function by
the nonenzymatic deamidation of asparagine and glutamine
residues (Robinson and Robinson, 2001). However, the finding
that two critical internal Asn residues in Bcl-XL, located within
an unstructured loop separating the 
1 (BH4 domain) and 
2
(BH3 domain) helices, can be deamidated in vivo in response
to DNA damage (Deverman et al., 2002) has suggested novel
Figure 8. A model integrating the findings of this paper
biological functions for protein deamidation. Our own findings
Pathway A refers to signals that are common to both intermediate activity suggest that inhibition of deamidation may be critical in the
p56lck (as in DN CD45/ or LckF505 thymocytes) and oncogenic p56lck (as
transforming events that lead to the development of T lympho-in DN CD45/LckF505 thymocytes). Pathways B and C are unique to the
oncogenic hyperactive p56lck found in DN CD45/LckF505 thymocytes. mas. The tight correlation between inhibition of Bcl-XL deamida-
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tion and preservation of the Bcl-XL-Bim interaction (Figure 7) (Baker et al., 2000). However, mutant LckF505 inhibits V(D)J re-
suggests that these two events might be linked. However, a combination, causing premature allelic exclusion (Anderson et
mutant version of Bcl-XL in which Asn-52 and Asn-66 were al., 1993), so in any case, the level of DSBs produced by the
changed to Asp residues has been reported to retain normal Rag enzymes is likely to be less in this context. Of possibly
Bim binding (Deverman et al., 2003). On the other hand, deami- greater significance is the DN3/DN4 proliferation induced by
dation of Asn residues typically leads to a preponderance of the active LckF505 transgene (Figure 3A): it is presumably the
isoaspartate over aspartate residues (Aswad et al., 2000; Aritomi reduction in DSB repair during subsequent cell divisions that
et al., 1997), so it remains possible that conversion of Asn-52 leads to the accumulation of DNA damage in pretumorigenic
and Asn-66 to isoaspartates in vivo might prevent Bim binding. LckF505CD45/ cells, consistent with the increase in basal
In addition, mutation of these Asn residues to Ala prevents Bcl- H2AX (Figure 4A) and p53 activation (Figure 5D). Even small
XL deamidation and promotes the prosurvival functions of Bcl- numbers of DSBs can be lethal, particularly if they occur during
XL, indicating a possible link between deamidation and Bcl-XL the replication of the genome and, if not repaired correctly, lead
function (Deverman et al., 2002). Protein deamidation may also to chromosomal abnormalities (Khanna and Jackson, 2001).
result in degradation (Sun et al., 1995), leading to increased An important conclusion from the present work is that a
Bcl-XL turnover. Nevertheless, as Figure 7B illustrates, the pres- modest 2- to 3-fold increase in activity of an OTK, brought about
ervation of Bcl-XL-Bim binding in pretumorigenic thymocytes in this case by CD45-deficiency (Figure 1), can convert the
cannot be explained by inhibition of Bcl-XL degradation. We kinase into an oncogene. Indeed, the key differences between
therefore envisage that in wild-type thymocytes, BH3-only pro- LckF505 and LckF505CD45/ thymocytes in response to DNA
tein(s) are sequestered by preferential binding to Bcl-XL (Letai damage (Figure 8) are all-or-nothing: the mutant LckF505 trans-
et al., 2002), so preventing their binding to Bax, in turn main- gene in a CD45/ environment neither inhibits DNA repair (Fig-
taining Bax in a conformational state that disfavors its transloca- ure 4A) nor provides protection from DNA-damage-induced
tion and oligomerization in mitochondrial membranes (Figure 7) apoptosis (Figures 5–7). The 2- to 3-fold increase in p56lck-F505
(Cheng et al., 2001; Marani et al., 2002). Following DNA damage, activity therefore appears to control a molecular switch rather
Bcl-XL is deamidated and its ability to sequester BH3-only pro- than a rheostat mechanism.
teins is compromised, causing their release and interaction with Although the present study was carried out on pretumori-
Bax, consequently triggering Bax mitochondrial translocation genic cells that displayed no overt signs of neoplasia, we have
and the subsequent release of cytochrome c and activation shown that hyperactive LckF505 causes high Bcl-XL expression
of the execution caspases (Figure 6). By inhibiting the DNA- in LckF505CD45/ lymphoma cells (Figure 7A), and preliminary
damage-triggered changes in Bcl-XL, hyperactive p56lck-F505 results (not shown) indicate that in this context Bcl-XL deamida-
thereby disrupts the cancer protection pathway that normally tion is also inhibited following DNA damage. A survey of the 60
disposes of cells with damaged DNA. Increased Bcl-XL expres- cell lines in an anticancer drug screen panel has previously
sion in response to an OTK (Figure 7A), as described for OTKs shown a striking correlation between Bcl-XL expression and
such as BCR-ABL (Amarante-Mendes et al., 1998), may there- resistance to a wide range of genotoxic compounds (Amundson
fore prove to be necessary but not sufficient for transformation. et al., 2000). Furthermore, OTKs such as BCR-ABL are known
Of course we also cannot exclude the possibility that other to upregulate Bcl-XL (Amarante-Mendes et al., 1998), and the
p56lck-F505-driven survival pathways contribute to oncogenesis. resistance of OTK-expressing tumors to chemo- and radiother-
It is intriguing that whereas “intermediate activity” p56lck-F505 apy represents one of the main causes of failure of antitumor
was almost 100% efficient at rescuing Rag/ DN3 cells from treatments (Skorski, 2002). It therefore seems feasible that phar-
apoptosis due to the failure of  selection (Figure 2), this kinase maceutical intervention to counteract the inhibition of the DNA-
activity level was incapable of rescuing the same cells from damage-induced Bcl-XL modifications described in the present
DNA-damage-induced apoptosis (Figure 5A). Presumably, in- work would not only prevent tumorigenesis caused by the ac-
termediate activity p56lck-F505 mimics pre-TCR mediated survival tions of an OTK, but could also promote the apoptosis of tumor
signals such as p53 inactivation and NFB activation in order cells in response to genotoxic agents.
to rescue DN3 thymocytes from apoptosis so completely (Haks
et al., 1999), although we have not specifically investigated these Experimental procedures
pathways. We assume that it is the additional level of regulation
Miceof Bcl-2 family members such as Bcl-XL in the context of DNA
All mice were bred and housed in specific pathogen-free conditions in thedamage that renders the hyperactive version of p56lck-F505 onco-
animal facility at The Babraham Institute, Cambridge, UK. The p56Lck-F505genic. Importantly, Bcl-XL expression per se does not appear
(PLGF-A) transgenic mice (Abraham et al., 1991) and the CD45/,essential for the progression of DN3 thymocytes through the 
CD45/LckF505, Rag/ LckF505, and Rag/CD45/LckF505 mice have been
selection checkpoint, consistent with this interpretation (Ma et previously described (Baker et al., 2000).
al., 1995).
The lethal combination of reduced DNA repair (Figure 4A) Flow cytometry
in conjunction with protection from DNA-damage-induced apo- Three-color or four-color analyses were carried out using a FACSCalibur
(Becton Dickinson). The following mAbs, labeled with FITC, PE, PerCP, orptosis (Figure 5A) is a potent predicator of genomic instability
Biotin, were purchased from Pharmingen (San Diego): CD4 (L3T4), CD8 (53-(Figures 4B and 4C). Genomic instability is increased as a conse-
6.7), CD3 (500A2), CD44 (Ly24), CD25 (PC61), NK1.1 (PK136), CD11B (M1/quence of V(D)J recombination events in DN2/DN3 thymic sub-
70), CD11C (HL3), B220 (RA3-6B2), Bcl-2 (3F11), H2AX, and respective
sets (Bassing et al., 2002). In light of the inhibition of DSB isotype controls. Streptavidin-APC (Caltag, Burlingame) was used to detect
repair noted in LckF505CD45/ thymocytes (Figure 4A), it might biotinylated mAbs. TUNEL (Tdt-mediated dUTP nick end labeling) staining
therefore seem surprising that the survival curves of of apoptotic cells employed the In Situ Cell Death Detection kit from Roche
(Mannheim, Germany). DNA staining was with 7-amino-actinomycin DLckF505CD45/ mice are not affected by a Rag-1/ background
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(7-AAD). DN3 and DN4 subsets were analyzed by first gating out thymocytes 24 hr). Chromosomal DNA size markers S. pombe and H. wingei were from
Biorad. Gels were stained with ethidium bromide and quantification of DNAstaining positive for biotinylated mAbs to CD3e, CD4, CD8, CD44, NK1.1,
CD11B, CD11C, and B220, followed by Streptavidin-FITC or Streptavidin- was obtained by phosphorimager analysis. The percentage of DNA con-
taining DSBs was determined as the integral density value of released DNAAPC. PE or PerCP-conjugated CD25 mAb was then used to identify the
DN3 subset, the CD25 cells representing the DN4 subset. from the plug/total DNA.
Karyotype analysis by chromosome paintingBrdU labeling
Mice were injected i.p. with 1 mg BrdU, and thymi were removed after 2 hr. Purified DN thymocytes were cultured in RPMI media supplemented with
10% FCS, L-Glutamine 1 mM, Pen/Strep 200 	g/ml, IL-4 10 ng/ml, andCells were first stained for surface antigen, and then fixed in 95% ethanol.
After 30 min on ice, cells were washed and resuspended in PBS with 1% PdBu 30 ng/ml. Cells were harvested 44 hr later. Mouse metaphases were
paraformaldehyde and 0.05% Tween 20, with incubation for 30 min at room prepared according to standard procedures. Mouse chromosome-specific
temperature. The cells were then centrifuged and resuspended in PBS sup- probes were made by degenerate oligonucleotide primed PCR from flow-
plemented with 4.2 mM Mgcl2, 10 	M HCL, and 100 U of DNase I. After sorted chromosomes according to the methods previously described (Fergu-
incubation at 25C for 30 min, the cells were washed and stained with BrdU- son-Smith, 1997; Telenius et al., 1992). Mouse rainbow FISH probe (Cambio,
FITC antibody (Becton Dickinson) for FACS analysis. Cambridge), which contains three sets of 7-color labeled mouse chromo-
some-specific paints (i.e., P1: chrs. 1–7; P2: chrs. 8–14; and P3: chrs. 15–Y),
Purification of DN thymocytes were used in this study following the manufacturer’s protocols. Each set of
Total thymocytes were incubated with CD3, CD4, and CD8 biotin-conjugated probes allows the simultaneous visualization of seven mouse chromosomes
antibodies, washed, and mixed with Dynabeads M-280 Streptavidin (Dynal, in one hybridization and thus the entire mouse genome in three hybridiza-
Oslo, Norway) with gentle rotation at 4C for 30 min. The immobilized cells tions. Chromosome painting and digital image analysis followed the methods
were isolated using a Magnetic Particle Concentrator (Dynal MPC). The described in Yang et al. (1995).
procedure was repeated once more to generate 97% pure DN thymocytes
(see Supplemental Figure S1 at http://www.cancercell.org/cgi/content/full/ Acknowledgments
5/1/37/DC1).
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Subcellular fractionation
Cells were washed in ice-cold PBS and resuspended in five vols of isotonic
mitochondria buffer: 210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 1 mM
EGTA, 10 mM Hepes (pH 7.5), and Complete Protease Inhibitors (Roche). Received: May 2, 2003
After 30 min incubation on ice, cells were homogenized and centrifuged at Revised: November 5, 2003
1000  g for 10 min at 4C. The supernatants were then centrifuged at Accepted: November 24, 2003
13,000  g for 15 min at 4C to obtain the pelleted mitochondrial fraction. Published: January 19, 2004
The supernatants were further centrifuged at 100,000  g for 90 min at 4C,
and the resulting supernatants designated as the cytosolic (S-100) fraction. References
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